top-selling glp-1 medications in the u.s. 2025 Trends: Costs & Coverage Barrier Amid Uncertainty GLP-1 boom makes Eli Lilly

Inflammatory intestinal diseases

There are many well-studied peptides not available in the U.S., like Semax, a peptide for stroke victims, and Selank, prescribed for anxiety

Those prices are roughly in line with much of the current market

Conclusion The findings suggest that initiation of tirzepatide and semaglutide is associated with different neuropsychiatric outcome patterns depending on the comparator treatment and the presence of type 2 diabetes

Impressively, Zepbound hitting 22,000 weekly prescription writings in its fourth week on the market compares to Mounjaro reaching just 8,101 prescriptions in its fourth week on the market

GHK-Cu reducing oxidative stress from hyperglycemia